Food and Drug Administration

Description

As part of Food and Drug Administration's Advancing Regulatory Science initiative the Office of Critical Path Programs (OCPP) supports innovation to improve the development and evaluation of new safe and effective medical products for diagnosing, treating, and preventing conditions and diseases. OCPP is working to harness new science and new technologies to further this goal.This Funding Opportunity Announcement (FOA) will provide resources for research into the development and qualification of alternative methodologies in the area of reproductive toxicology, which have the potential to be more predictive than the currently required testing, and which will reduce, refine, or replace animal testing.Applications should address the Critical Path Initiative's mission to facilitate the development of new safe and effective products for diagnosing, treating, and preventing disease.

Who can apply

• Nonprofits with 501(c)(3) status (other than higher education)
• Private institutions of higher education

Contact

Gladys M. Bohler <br/>Grants Management Officer/Specialist <br/>Phone 301-827-7175
gmbohler@fda.hhs.gov